Novo Nordisk Partners with Emcure to Expand Access to Weight-Loss Drug Poviztra in India

Novo Nordisk India has joined hands with Emcure Pharmaceuticals to commercialize Poviztra, a second brand of its blockbuster weight-loss therapy Wegovy (semaglutide 2.4 mg).